Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) has been given an average rating of "Moderate Buy" by the eight ratings firms that are currently covering the stock, MarketBeat Ratings...